Rafferty Asset Management
LNAI

Rafferty Asset Management’s Lunai Bioworks LNAI Stock Holding History

Rafferty Asset Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-328
Closed -$48K – 1151
2022
Q3 		$48K Buy
328
+12
+4% +$2.19K ﹤0.01% 1134
2022
Q2 		$49K Buy
316
+109
+53% +$49.9K ﹤0.01% 1104
2022
Q1 		$137K Buy
+207
New +$110K ﹤0.01% 1160

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rafferty Asset Management's LNAI Position: Q4 2022 in Review

Rafferty Asset Management sold out of Lunai Bioworks (LNAI) in Q4 2022, closing a stake of 328 shares — an estimated $48K sold.

Rafferty Asset Management first reported a position in LNAI in Q1 2022 and held it in 3 quarters. The position peaked at $137K in Q1 2022. 36 funds tracked by Wall St. Rank hold LNAI as of Q4 2022.

  • Rafferty Asset Management reported no remaining Lunai Bioworks position as of Q4 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 328 Lunai Bioworks shares in Q4 2022, an estimated $48K.
  • Rafferty Asset Management first reported a position in Lunai Bioworks in Q1 2022 and held it in 3 quarters.
  • Rafferty Asset Management's Lunai Bioworks position peaked at $137K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2022.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.